ABBOTT LABORATORIES Long-Term Debt 2007-2026 | ABT
Beta
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is ABBOTT LABORATORIES's current long-term debt?
ABBOTT LABORATORIES (ABT) annual long-term debt for 2025 was $9.90B, a 21.62% decline from 2024. ABBOTT LABORATORIES long-term debt for the quarter ending March 31, 2026 was $29.64B.
What was ABBOTT LABORATORIES's long-term debt in 2024?
ABBOTT LABORATORIES annual long-term debt for 2024 was $12.63B, a 7.16% decline from 2023.
What was ABBOTT LABORATORIES's long-term debt in 2023?
ABBOTT LABORATORIES annual long-term debt for 2023 was $13.60B, a 6.36% decline from 2022.
What is ABBOTT LABORATORIES's 5-year long-term debt CAGR?
ABBOTT LABORATORIES long-term debt grew at a compound annual growth rate (CAGR) of 11.79% from FY2020 to FY2025, going from $18.53B to $9.90B over 5 years.
Long-Term Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR-11.8%
FY2020
$18.53B
→
FY2025
$9.90B
07080910111213141516171819202122232425
5 years selected
Long-Term Debt History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.90B | -21.6% | 10-K |
| FY2024 | $12.63B | -7.2% | 10-K |
| FY2023 | $13.60B | -6.4% | 10-K |
| FY2022 | $14.52B | -16.0% | 10-K |
| FY2021 | $17.30B | -6.6% | 10-K |
| FY2020 | $18.53B | +11.2% | 10-K |
| FY2019 | $16.66B | -13.9% | 10-K |
| FY2018 | $19.36B | -28.9% | 10-K |
| FY2017 | $27.21B | +31.6% | 10-K |
| FY2016 | $20.68B | +252.3% | 10-K |
| FY2015 | $5.87B | +73.0% | 10-K |
| FY2014 | $3.39B | +0.1% | 10-K |
| FY2013 | $3.39B | -81.3% | 10-K |
| FY2012 | $18.09B | +50.2% | 10-K |
| FY2011 | $12.04B | -3.9% | 10-K |
| FY2010 | $12.52B | +11.2% | 10-K |
| FY2009 | $11.27B | +29.3% | 10-K |
| FY2008 | $8.71B | -8.2% | 10-K |
| FY2007 | $9.49B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →